Metagenomi, Common Net Receivables Over Time
| MGX Stock | 2.07 0.05 2.48% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Metagenomi, Common Performance and Metagenomi, Common Correlation. Metagenomi, |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Metagenomi, Common. If investors know Metagenomi, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Metagenomi, Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.00) | Revenue Per Share 3.758 | Quarterly Revenue Growth 0.765 | Return On Assets (0.14) | Return On Equity (0.29) |
The market value of Metagenomi, Common Stock is measured differently than its book value, which is the value of Metagenomi, that is recorded on the company's balance sheet. Investors also form their own opinion of Metagenomi, Common's value that differs from its market value or its book value, called intrinsic value, which is Metagenomi, Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Metagenomi, Common's market value can be influenced by many factors that don't directly affect Metagenomi, Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Metagenomi, Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if Metagenomi, Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Metagenomi, Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Receivables Analysis
Compare Metagenomi, Common Stock and related stocks such as Tower One Wireless, Nike Inc, and Globalfoundries Net Receivables Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NKE | 185.6 M | 3.3 B | 3.1 B | 3.4 B | 3.4 B | 3.2 B | 3.7 B | 3.5 B | 4.3 B | 2.7 B | 4.5 B | 4.7 B | 4.1 B | 4.4 B | 2.5 B |
| GFS | 2.1 B | 2.1 B | 2.1 B | 2.1 B | 2.1 B | 2.1 B | 2.1 B | 2.1 B | 2.1 B | 2.1 B | 1 B | 915 M | 1.4 B | 1.4 B | 1.1 B |
| FKWL | 400 K | 13.3 M | 5.5 M | 5.7 M | 5.6 M | 12.4 M | 11.1 M | 8 M | 4.2 M | 16 M | 2.6 M | 1.4 M | 9.1 M | 1.2 M | 1.1 M |
| KLIC | 16.8 M | 189 M | 162.7 M | 171.5 M | 108.6 M | 130.5 M | 198.5 M | 243.4 M | 195.8 M | 198.6 M | 421.2 M | 309.3 M | 168.8 M | 193.9 M | 130.3 M |
| HNI | 59.7 M | 204 M | 213.5 M | 228.7 M | 240.1 M | 243.4 M | 229.4 M | 258.6 M | 255.2 M | 274.6 M | 202.5 M | 237.1 M | 218.1 M | 246.7 M | 195.1 M |
| MX | 159.5 M | 126.2 M | 144.8 M | 84.9 M | 84.9 M | 95.4 M | 67.6 M | 96.3 M | 121.9 M | 123 M | 68.7 M | 76.8 M | 43.2 M | 36.9 M | 35.1 M |
| SKX | 49.2 M | 182.7 M | 221.2 M | 236.5 M | 288.6 M | 362.6 M | 346 M | 433 M | 557.6 M | 699.2 M | 689 M | 812.8 M | 934.3 M | 942.6 M | 989.7 M |
Metagenomi, Common Stock and related stocks such as Tower One Wireless, Nike Inc, and Globalfoundries Net Receivables description
My Equities
My Current Equities and Potential Positions
| Metagenomi, Common Stock | MGX |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
null 2.07
Additional Tools for Metagenomi, Stock Analysis
When running Metagenomi, Common's price analysis, check to measure Metagenomi, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Metagenomi, Common is operating at the current time. Most of Metagenomi, Common's value examination focuses on studying past and present price action to predict the probability of Metagenomi, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Metagenomi, Common's price. Additionally, you may evaluate how the addition of Metagenomi, Common to your portfolios can decrease your overall portfolio volatility.